» Articles » PMID: 29499058

Short- and Long-term Prognostic Value of Hyponatremia in Patients with Acute Coronary Syndrome: A Systematic Review and Meta-analysis

Overview
Journal PLoS One
Date 2018 Mar 3
PMID 29499058
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Hyponatremia is relevant to heart failure, liver cirrhosis and stroke, but the prognostic value of serum sodium levels in patients with acute coronary syndrome are still unclear. So we did a systematic review and meta-analysis to assess the prognostic value of hyponatremia on adverse events in patients after ACS. We systematically searched PubMed, Embase and Cochrane Library to find literatures which studied the prognostic value of hyponatremia in patients with ACS. Our main endpoints were the all-cause mortality and heart failure in the short- and long-term. Of 369 identified studies, 20 studies were included in our analysis. Compared with the normal natrium, hyponatremia was significantly associated with the increased risks of all-cause mortality within 30 days (RR: 2.18; 95%CI: 1.96-2.42) and during the follow-ups (HR: 1.74; 95%CI: 1.56-1.942). For the second endpoint of short- and long-term heart failure, the pooled effect sizes in hyponatremia patients were 1.72(95%CI: 1.38-2.14) and 1.69(95%CI: 1.12-2.55) respectively. In conclusion, hyponatremia has a significant prognostic value for short- and long-term adverse event in patients after ACS, the dynamic monitoring of serum sodium levels may could help physicians to identify high risk ACS patients and to stratify risk for optimal management.

Citing Articles

Long-Term Clinical Relevance of Hyponatremia Identified During Acute Phase of Myocardial Infarction.

Eliasz K, Stepien K, Wojtylak M, Andrasz O, Majka K, Mazurek G J Clin Med. 2025; 14(3).

PMID: 39941632 PMC: 11818574. DOI: 10.3390/jcm14030962.


Hyponatremia after COVID-19 is frequent in the first year and increases re-admissions.

Biagetti B, Sanchez-Montalva A, Puig-Perez A, Campos-Varela I, Pilia M, Anderssen-Nordahl E Sci Rep. 2024; 14(1):595.

PMID: 38182711 PMC: 10770325. DOI: 10.1038/s41598-023-50970-z.


Hyponatremia in patients with arterial hypertension: pathophysiology and management.

Adamczak M, Surma S, Wiecek A Arch Med Sci. 2023; 19(6):1630-1645.

PMID: 38058704 PMC: 10697001. DOI: 10.5114/aoms/161578.


Integrated bioinformatics and machine learning algorithms reveal the critical cellular senescence-associated genes and immune infiltration in heart failure due to ischemic cardiomyopathy.

Guo L, Xu C Front Immunol. 2023; 14:1150304.

PMID: 37234159 PMC: 10206252. DOI: 10.3389/fimmu.2023.1150304.


A step-by-step guide for the diagnosis and management of hyponatraemia in patients with stroke.

Barkas F, Anastasiou G, Liamis G, Milionis H Ther Adv Endocrinol Metab. 2023; 14:20420188231163806.

PMID: 37033701 PMC: 10074625. DOI: 10.1177/20420188231163806.


References
1.
Latini R, Masson S, Anand I, Salio M, Hester A, Judd D . The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J. 2004; 25(4):292-9. DOI: 10.1016/j.ehj.2003.10.030. View

2.
Tierney J, Stewart L, Ghersi D, Burdett S, Sydes M . Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007; 8:16. PMC: 1920534. DOI: 10.1186/1745-6215-8-16. View

3.
Klopotowski M, Kruk M, Przyluski J, Kalinczuk L, Pregowski J, Bekta P . Sodium level on admission and in-hospital outcomes of STEMI patients treated with primary angioplasty: the ANIN Myocardial Infarction Registry. Med Sci Monit. 2009; 15(9):CR477-83. View

4.
Yang X, Zhao L, Zheng Q, Li X . Effects of arginine vasopressin on growth of rat cardiac fibroblasts: role of V1 receptor. J Cardiovasc Pharmacol. 2003; 42(1):132-5. DOI: 10.1097/00005344-200307000-00020. View

5.
Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View